Literature DB >> 29191974

First targeted therapy in multiple myeloma.

K Martin Kortüm1, Hermann Einsele1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29191974     DOI： 10.1182/blood-2017-09-805341

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  Multiple myeloma with t(11;14): unique biology and evolving landscape.

Authors:  Susan Bal; Shaji K Kumar; Rafael Fonseca; Francesca Gay; Vania Tm Hungria; Ahmet Dogan; Luciano J Costa
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

Review 2.  A review on tumor heterogeneity and evolution in multiple myeloma: pathological, radiological, molecular genetics, and clinical integration.

Authors:  Christian M Schürch; Leo Rasche; Leonie Frauenfeld; Niels Weinhold; Falko Fend
Journal:  Virchows Arch       Date:  2019-12-17       Impact factor: 4.064

3.  Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients.

Authors:  Dickran Kazandjian; Elizabeth Hill; Malin Hultcrantz; Evan H Rustad; Venkata Yellapantula; Theresia Akhlaghi; Neha Korde; Sham Mailankody; Alex Dew; Elli Papaemmanuil; Irina Maric; Mary Kwok; Ola Landgren
Journal:  Blood Cancer J       Date:  2019-02-04       Impact factor: 11.037

Review 4.  High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.

Authors:  Antonio Giovanni Solimando; Matteo Claudio Da Vià; Sebastiano Cicco; Patrizia Leone; Giuseppe Di Lernia; Donato Giannico; Vanessa Desantis; Maria Antonia Frassanito; Arcangelo Morizio; Julia Delgado Tascon; Assunta Melaccio; Ilaria Saltarella; Giuseppe Ranieri; Roberto Ria; Leo Rasche; K Martin Kortüm; Andreas Beilhack; Vito Racanelli; Angelo Vacca; Hermann Einsele
Journal:  J Clin Med       Date:  2019-07-09       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.